330 related articles for article (PubMed ID: 15630899)
1. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
2. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
[TBL] [Abstract][Full Text] [Related]
4. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
[TBL] [Abstract][Full Text] [Related]
5. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
Tanaka H; Oki E; Tsuruga K; Sato N; Matsukura H; Matsunaga A; Kondo Y; Suzuki J
Nephron Clin Pract; 2008; 110(2):c73-9. PubMed ID: 18758186
[TBL] [Abstract][Full Text] [Related]
6. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Ito E; Waga S
Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
[TBL] [Abstract][Full Text] [Related]
7. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
Yoshidome K; Takei S; Imanaka H; Maeno N; Ohkawa T; Kawano Y
Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
[TBL] [Abstract][Full Text] [Related]
9. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Tsubouchi Y; Fukuda W; Kawahito Y; Kohno M; Wada M; Ishino H; Hamaguchi M; Yamamoto A; Kadoya M; Niimi M; Yoshikawa T
Mod Rheumatol; 2008; 18(1):91-5. PubMed ID: 18159569
[TBL] [Abstract][Full Text] [Related]
10. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
Tanaka H; Tsugawa K; Oki E; Suzuki K; Ito E
Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
[TBL] [Abstract][Full Text] [Related]
11. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
[TBL] [Abstract][Full Text] [Related]
12. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Zhang M; Xing CY; Liu J
Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
[TBL] [Abstract][Full Text] [Related]
13. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
Nomura A; Shimizu H; Kishimoto M; Suyama Y; Rokutanda R; Ohara Y; Yamaguchi K; Okada M
Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
[TBL] [Abstract][Full Text] [Related]
16. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
Kuroda T; Hirose S; Tanabe N; Sato H; Nakatsue T; Ajiro J; Wada Y; Murakami S; Hasegawa H; Ito S; Sakatsume M; Nakano M; Gejyo F
Mod Rheumatol; 2007; 17(3):206-12. PubMed ID: 17564775
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
Tanaka H; Aizawa T; Watanabe S; Oki E; Tsuruga K; Imaizumi T
Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
[TBL] [Abstract][Full Text] [Related]
19. Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.
Tanaka H; Oki E; Tsuruga K; Aizawa-Yashiro T; Ito Y; Sato N; Kawasaki Y; Suzuki J
Clin Rheumatol; 2010 Sep; 29(9):1049-54. PubMed ID: 20490589
[TBL] [Abstract][Full Text] [Related]
20. Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
Ito T; Mochizuki K; Oka T; Hanada K; Tanabe K
Int Urol Nephrol; 2015 Jan; 47(1):131-5. PubMed ID: 25298141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]